Mathias Uhlen

Dr Uhlen is a professor at the Royal Institute of Technology (KTH), Stockholm, Sweden. His research is focused on protein science, antibody engineering and precision medicine and range from basic research to more applied research, including clinical applications in cancer, infectious diseases, cardiovascular diseases, autoimmune diseases and neurobiology. The research has resulted in more than 550 publications with a current h-index of 98 (Google Scholar). Since 2003, he has led an international effort to systematically map the human proteome with antibodies and to create an open source knowledge-based resource called the Human Protein Atlas (www.proteinatlas.org). Based on the Protein Atlas effort (Uhlen et al, Science, 2015), he has launched a new wellness profiling effort in which individuals have been monitored every three months and analyzed using whole genome sequencing, cell analysis, proteomics, metabolomics and microbiome analysis. He is member of the National Academy of Engineering (NAE) in USA, the Royal Swedish Academy of Science (KVA), the Swedish Academy of Engineering Science (IVA) and the European Molecular Biology Organization (EMBO).. He was, starting in 2010, the founding Director of the Science for Life Laboratory (SciLifeLab), a national center for molecular bioscience (www.scilifelab.se).